<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25326335</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-160X</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Rheumatology international</Title><ISOAbbreviation>Rheumatol Int</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis of associations between functional HLA-G polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis.</ArticleTitle><Pagination><StartPage>953</StartPage><EndPage>961</EndPage><MedlinePgn>953-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00296-014-3155-3</ELocationID><Abstract><AbstractText>The aim of this study was to determine whether the functional HLA-G 14 bp insertion (I)/deletion (D) and +3142 G/C polymorphisms are associated with susceptibility to systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). A meta-analysis was conducted on the associations between the HLA-G 14 bp I/D, and +3142 G/C polymorphisms and SLE or RA using; (1) allele contrast, (2) the recessive model, (3) the dominant model, and (4) additive model. A total of 14 comparison studies from 11 articles met our inclusion criteria, comprising eight on SLE (1,284 patients and 1,885 controls) and four on RA (820 patients and 772 controls), and three studies investigated response to methotrexate (MTX) in RA according to the HLA-G 14 bp I/D polymorphisms (249 responders and 205 nonresponders). Meta-analysis revealed an association between the II + ID genotype of the HLA-G 14 bp I/D polymorphism in overall group (OR = 1.205, 95% CI = 1.036-1.403, P = 0.016). Ethnicity-specific meta-analysis showed no association between the II + ID genotype and SLE in the South American, European, and Asian population. Meta-analysis revealed a significant association between SLE and the HLA-G +3142 G allele in all study subjects (OR = 1.367, 95% CI = 1.158-1.613, P = 2.2 &#xd7; 10(-5)) and in the South American group (OR = 1.531, 95% CI = 1.242-1.888, P = 6.7 &#xd7; 10(-5)). However, no association between HLA-G 14 bp I/D, and +3142 G/C polymorphisms and RA was found (OR for HLA-G I allele = 1.013, 95 % CI = 0.879-1.167, P = 0.859; OR for +3142 G allele = 0.980, 95% CI = 0.742-1.294, P = 0.888). Furthermore, HLA-G 14 bp I/D polymorphism was not found to be associated with response to MTX in RA. This meta-analysis demonstrates that the HLA-G 14 bp I/D polymorphism is associated with susceptibility to SLE, and HLA-G +3142 G/C polymorphisms are associated with susceptibility to SLE in South Americans.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Young Ho</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, 126-1, Anam-dong 5 ga, Seongbuk-gu, Seoul, 136-705, Korea, lyhcgh@korea.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Sang-Cheol</ForeName><Initials>SC</Initials></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Gwan Gyu</ForeName><Initials>GG</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Rheumatol Int</MedlineTA><NlmUniqueID>8206885</NlmUniqueID><ISSNLinking>0172-8172</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059951">HLA-G Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059951" MajorTopicYN="N">HLA-G Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="Y">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25326335</ArticleId><ArticleId IdType="doi">10.1007/s00296-014-3155-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lupus. 2009 Apr;18(5):424-30</Citation><ArticleIdList><ArticleId IdType="pubmed">19318395</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2006 Feb;45(2):166-70</Citation><ArticleIdList><ArticleId IdType="pubmed">16278286</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Rep. 2011 Aug;38(6):3643-51</Citation><ArticleIdList><ArticleId IdType="pubmed">21110115</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Rep. 2012 Apr;39(4):3453-60</Citation><ArticleIdList><ArticleId IdType="pubmed">21706348</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1997 Sep 13;315(7109):629-34</Citation><ArticleIdList><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissue Antigens. 2008 Jun;71(6):520-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18380776</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Oct;81(4):829-34</Citation><ArticleIdList><ArticleId IdType="pubmed">17847008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2009 Jan;68(1):154-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19088262</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2014 Apr;31(2):228-32</Citation><ArticleIdList><ArticleId IdType="pubmed">24711038</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2000 Feb;30(2):586-93</Citation><ArticleIdList><ArticleId IdType="pubmed">10671215</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1986 Sep;7(3):177-88</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Res Methods. 2009 Nov;41(4):1149-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19897823</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacogenet Genomics. 2006 Sep;16(9):615-23</Citation><ArticleIdList><ArticleId IdType="pubmed">16906016</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2002 Jun 15;21(11):1539-58</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatol Int. 2007 Jul;27(9):827-33</Citation><ArticleIdList><ArticleId IdType="pubmed">17265154</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1997 Dec 6;315(7121):1533-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9432252</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Genet. 2005 Dec;118(3-4):434-43</Citation><ArticleIdList><ArticleId IdType="pubmed">16208513</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus. 2009 Dec;18(14):1259-66</Citation><ArticleIdList><ArticleId IdType="pubmed">19884219</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissue Antigens. 2011 Jun;77(6):540-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21395561</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2013 Jul;40(7):1104-13</Citation><ArticleIdList><ArticleId IdType="pubmed">23678155</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissue Antigens. 2014 Apr;83(4):260-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24580026</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissue Antigens. 2014 Sep;84(3):308-15</Citation><ArticleIdList><ArticleId IdType="pubmed">24957665</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacogenomics. 2010 Feb;11(2):163-75</Citation><ArticleIdList><ArticleId IdType="pubmed">20136356</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Immunol. 2001 Oct;22(10):553-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11574278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 2003 Nov;64(11):1005-10</Citation><ArticleIdList><ArticleId IdType="pubmed">14602228</ArticleId></ArticleIdList></Reference><Reference><Citation>J Reprod Immunol. 2000 Aug;48(1):17-26</Citation><ArticleIdList><ArticleId IdType="pubmed">10996380</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>